Network origin in Ralf Morgenstern first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ralf Morgenstern via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chief Operating Officer | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Collective Minds Radiology AB
 Collective Minds Radiology AB Packaged SoftwareTechnology Services Collective Minds Radiology AB provides a cloud-based healthcare service that enables collaboration, consultation, and access to new digital tools. The company is based in Danderyd, Sweden. The Swedish company was founded in 2017 by Pär Kragsterman, Anders Nordell, and Lennart Blomqvist. Anders Nordell has been the CEO since 2017. | Packaged Software | Director/Board Member | |
| Urban Paulsson AB | Chairman | ||
Nylof Holding AB
 Nylof Holding AB Investment Banks/BrokersFinance Nylof Holding AB provides security brokerage services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman | |
| Cordivest AB | Chairman | ||
| MetaCurUm Biotech AB | Chairman | ||
| Brf-Bellman | Chairman | ||
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Operating Officer | |
Molecules of Man AB
 Molecules of Man AB BiotechnologyHealth Technology Molecules of Man AB develops human monoclonal antibodies for treatment. The private company is based in Stockholm, Sweden. | Biotechnology | Chairman | |
| Cavis Technologies AB | Chairman | ||
| Evident Life Försäkring AB | Chairman | ||
Buzzard Pharmaceuticals AB
 Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Founder | |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Founder | |
| NANEXA AB | Medical Specialties | Director/Board Member | |
| University of Lund | College/University | Graduate Degree | |
Nordia Law
 Nordia Law Miscellaneous Commercial ServicesCommercial Services Nordia Law provides legal services. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CAMURUS AB | Pharmaceuticals: Major | General Counsel | |
| VITROLIFE AB | Medical Specialties | General Counsel | |
| The Swedish Bar Association | Corporate Officer/Principal | ||
| Life Science Group, Inc. | Medical Specialties | Corporate Officer/Principal | |
Bird & Bird LLP
 Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Bird & Bird LLP provide legal services. The firm focuses on aviation and aerospace, banking and financial services, communications, eCommerce, information technology, life sciences, media, and sports sectors. The company was founded in 1846 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Liberum Capital Ltd.
 Liberum Capital Ltd. Investment Banks/BrokersFinance Liberum Capital Ltd. (Liberum) is a brokerage firm headquartered in London, UK. The firm was founded by Shane Le Prevost in 2007 to provide a different style of broking. They were acquired by Panmure Liberum Ltd. from TN Holdings (BVI) Ltd. in 2024. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in various large, mid and small-cap stocks. | Investment Banks/Brokers | Analyst-Equity | |
| Copenhagen Business School | College/University | Graduate Degree | |
| Betagenon Bio AB | Chairman | ||
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chairman | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
| Olsson Solutions AB | Director/Board Member | ||
| International Institute for Management Development | College/University | Undergraduate Degree | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
| BioCrine AB | Director/Board Member | ||
| The European Society of Cardiology | Director/Board Member | ||
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| Stockholm School of Economics | College/University | Graduate Degree | |
| BIOSERVO TECHNOLOGIES AB | Medical Specialties | Director/Board Member | |
A.A.G. Aalborg Gummivarefabrik A/S
 A.A.G. Aalborg Gummivarefabrik A/S Miscellaneous ManufacturingProducer Manufacturing A.A.G. Aalborg Gummivarefabrik A/S is a holding company engage in manufacturing and processing technical rubber products. Its products include sheeting and plates, profiles, gaskets, pur and plastic, stable mats, mats and flooring, polyvinyl chloride doors, and accessories. It also offers items such as vibration insulators, rubber protectors and footings, custom made fender, polyurethane, playgrounds, damper, and scraper flooring solutions. The company was founded on June 29, 1979 and is headquartered in Norresundby, Denmark. | Miscellaneous Manufacturing | Corporate Officer/Principal |
Statistics
International
| Sweden | 40 |
| United States | 6 |
| Denmark | 3 |
| Australia | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 2 |
Operational
| Director/Board Member | 72 |
| Corporate Officer/Principal | 29 |
| Independent Dir/Board Member | 16 |
| Chairman | 15 |
| Founder | 10 |
Most connected contacts
- Stock Market
- Insiders
- Ralf Morgenstern
- Company connections
